https://www.npr.org/sections/health-sho ... in-the-u-s
View the data via state-by-state charts (immediately below), a heat map that shows state risk levels, a table of trends in new infections over four weeks, and a map of case and death totals.
View the data via state-by-state charts (immediately below), a heat map that shows state risk levels, a table of trends in new infections over four weeks, and a map of case and death totals.
To understand how the pandemic is evolving, it’s crucial to know how death rates from COVID-19 are affected by vaccination status.
by Edouard Mathieu and Max Roser
November 23, 2021
In this systematic review and meta-analysis, approximately one-third of placebo recipients in COVID-19 vaccine randomized clinical trials reported at least 1 systemic AE after both the first and the second dose, with headache and fatigue being the most common. This nocebo response accounted for 76.0% of systemic AEs after the first dose of COVID-19 vaccine, and for 51.8% after the second dose. Public vaccination programs should consider these high nocebo responses.
Interesting stats.
I also forgot that over time, the fact that it hit the elderly so hard up front (at the time when no vaxx was available, and therefore every hospitalization or death would be "unvaxxed") and the development of actual treatment methods and drugs over time (which would overlap vaxx status because of the time delay in getting the vaxx developed) might impact rates quite a bit, as well.Ben Trovado wrote: ↑Tue Jan 18, 2022 10:37 pmInteresting stats.
It looks like a x5 or x6 rough advantage for the 2 best vacc's.
Of course, I just took a quick look, and am not sure some of it isn't a bit fudged. The incentive to label deaths a caused by covid (financial) was greater until recently. Likewise, the recent strain is less lethal . . . I'd really need to look at it month by month to get a clear picture.
Still. Useful.
Disclaimer
VAERS accepts reports of adverse events and reactions that occur following vaccination. Healthcare providers, vaccine manufacturers, and the public can submit reports to the system. While very important in monitoring vaccine safety, VAERS reports alone cannot be used to determine if a vaccine caused or contributed to an adverse event or illness. The reports may contain information that is incomplete, inaccurate, coincidental, or unverifiable. In large part, reports to VAERS are voluntary, which means they are subject to biases. This creates specific limitations on how the data can be used scientifically. Data from VAERS reports should always be interpreted with these limitations in mind.
The strengths of VAERS are that it is national in scope and can quickly provide an early warning of a safety problem with a vaccine. As part of CDC and FDA’s multi-system approach to post-licensure vaccine safety monitoring, VAERS is designed to rapidly detect unusual or unexpected patterns of adverse events, also known as “safety signals.” If a safety signal is found in VAERS, further studies can be done in safety systems such as the CDC’s Vaccine Safety Datalink (VSD) or the Clinical Immunization Safety Assessment (CISA) project. These systems do not have the same scientific limitations as VAERS, and can better assess health risks and possible connections between adverse events and a vaccine.
It's over my head.Pyrrho wrote: ↑Mon Jan 24, 2022 5:19 pm Best to conduct one's own search of VAERS data.
https://vaers.hhs.gov/data.html
Disclaimer
VAERS accepts reports of adverse events and reactions that occur following vaccination. Healthcare providers, vaccine manufacturers, and the public can submit reports to the system. While very important in monitoring vaccine safety, VAERS reports alone cannot be used to determine if a vaccine caused or contributed to an adverse event or illness. The reports may contain information that is incomplete, inaccurate, coincidental, or unverifiable. In large part, reports to VAERS are voluntary, which means they are subject to biases. This creates specific limitations on how the data can be used scientifically. Data from VAERS reports should always be interpreted with these limitations in mind.
The strengths of VAERS are that it is national in scope and can quickly provide an early warning of a safety problem with a vaccine. As part of CDC and FDA’s multi-system approach to post-licensure vaccine safety monitoring, VAERS is designed to rapidly detect unusual or unexpected patterns of adverse events, also known as “safety signals.” If a safety signal is found in VAERS, further studies can be done in safety systems such as the CDC’s Vaccine Safety Datalink (VSD) or the Clinical Immunization Safety Assessment (CISA) project. These systems do not have the same scientific limitations as VAERS, and can better assess health risks and possible connections between adverse events and a vaccine.
He's cherry-picking. It's over his head, too.Tommy Palven wrote: ↑Mon Jan 24, 2022 10:14 pmIt's over my head.Pyrrho wrote: ↑Mon Jan 24, 2022 5:19 pm Best to conduct one's own search of VAERS data.
https://vaers.hhs.gov/data.html
Disclaimer
VAERS accepts reports of adverse events and reactions that occur following vaccination. Healthcare providers, vaccine manufacturers, and the public can submit reports to the system. While very important in monitoring vaccine safety, VAERS reports alone cannot be used to determine if a vaccine caused or contributed to an adverse event or illness. The reports may contain information that is incomplete, inaccurate, coincidental, or unverifiable. In large part, reports to VAERS are voluntary, which means they are subject to biases. This creates specific limitations on how the data can be used scientifically. Data from VAERS reports should always be interpreted with these limitations in mind.
The strengths of VAERS are that it is national in scope and can quickly provide an early warning of a safety problem with a vaccine. As part of CDC and FDA’s multi-system approach to post-licensure vaccine safety monitoring, VAERS is designed to rapidly detect unusual or unexpected patterns of adverse events, also known as “safety signals.” If a safety signal is found in VAERS, further studies can be done in safety systems such as the CDC’s Vaccine Safety Datalink (VSD) or the Clinical Immunization Safety Assessment (CISA) project. These systems do not have the same scientific limitations as VAERS, and can better assess health risks and possible connections between adverse events and a vaccine.
Have you conducted your own search?
If so, in your opinion is there any truth to what Kennedy is saying?
That said, yes, there are incidents of adverse effects post-vaccination. It is unfortunate, no argument there. COVID-19 has an extremely higher incidence of adverse effects. The benefits of the vaccines outweigh the risks, even with the unfortunate occurrences of severe adverse effects, which nobody intends.The reports may contain information that is incomplete, inaccurate, coincidental, or unverifiable. In large part, reports to VAERS are voluntary, which means they are subject to biases. This creates specific limitations on how the data can be used scientifically. Data from VAERS reports should always be interpreted with these limitations in mind.
With respect, how can you claim a definitive position when the evidence necessary to arrive at degree of position proves "over your head?"
Let me just make a simple observation and calculation from the information on that page:Tommy Palven wrote: ↑Mon Jan 24, 2022 2:27 pm Kennedy's group. Truth or lies?
https://childrenshealthdefense.org/defe ... ies-teens/
Christian extremists may support Kennedy for the wrong reasons, but is he wrong?
In the United States, using 2019 numbers, there were 2,854,838 deaths. That's 7152 deaths per 1 million people in a year. A year has 365 days, so that's 19.5 deaths per million per day. So typically, if you give 1 million shots, you would expect 19.5 of those people to die within 24 hours of getting the shot and 39 people to die within 48 hours. That's for 1 million. According to the above, "516 million COVID vaccine doses had been administered as of Jan. 7". Simple multiplication shows that you would expect 10,062 people to die within 24 hours and double that (20,124) within 48 hours.Excluding “foreign reports” to VAERS, 723,042 adverse events, including 9,936 deaths and 64,406 serious injuries, were reported in the U.S. between Dec. 14, 2020, and Jan. 7, 2022.
Foreign reports are reports foreign subsidiaries send to U.S. vaccine manufacturers. Under U.S. Food and Drug Administration (FDA) regulations, if a manufacturer is notified of a foreign case report that describes an event that is both serious and does not appear on the product’s labeling, the manufacturer is required to submit the report to VAERS.
Of the 9,936 U.S. deaths reported as of Jan. 7, 19% occurred within 24 hours of vaccination, 24% occurred within 48 hours of vaccination and 61% occurred in people who experienced an onset of symptoms within 48 hours of being vaccinated.
In the U.S., 516 million COVID vaccine doses had been administered as of Jan. 7, including 303 million doses of Pfizer, 197 million doses of Moderna and 18 million doses of Johnson & Johnson (J&J).
What now?Ben Trovado wrote: ↑Wed Jan 26, 2022 11:39 pmI will say that the fact that the % of vaccinated people either hospitalized or dead match so closely to the % of people vaccinated overall. . . .
No idea. On balance, I support the vaccines for anyone over 50 definitely. Over 30 Probably. Over 15 Maybe, according to other factors. And under 15, probably not, according to other factors.Doctor X wrote: ↑Thu Jan 27, 2022 1:30 amWhat now?Ben Trovado wrote: ↑Wed Jan 26, 2022 11:39 pmI will say that the fact that the % of vaccinated people either hospitalized or dead match so closely to the % of people vaccinated overall. . . .
– J.D.
I think he was questioning your premise. If it's true, yeah, that would be strange, but most information I have seen doesn't seem to show that.Ben Trovado wrote: ↑Thu Jan 27, 2022 1:59 amNo idea. On balance, I support the vaccines for anyone over 50 definitely. Over 30 Probably. Over 15 Maybe, according to other factors. And under 15, probably not, according to other factors.Doctor X wrote: ↑Thu Jan 27, 2022 1:30 amWhat now?Ben Trovado wrote: ↑Wed Jan 26, 2022 11:39 pmI will say that the fact that the % of vaccinated people either hospitalized or dead match so closely to the % of people vaccinated overall. . . .
– J.D.
But I am just one rando looking out for himself and his kids.
Note that this is recent data, not from last summer. Hospitalization rates were 5 times higher in unvaccinated 12-34 year-olds and 7 times higher in people 35 or older. And from Dec. 1 to Dec. 28th death rates were 11 times higher for unvaccinated people over 65.COVID-19 hospitalization rates per 100,000 population from December 15 to
January 11, 2022
That is one reason that the Israel numbers are hard to explain. I think they raise issues, but aren't definitive on anything.Anaxagoras wrote: ↑Thu Jan 27, 2022 2:20 amI think he was questioning your premise. If it's true, yeah, that would be strange, but most information I have seen doesn't seem to show that.Ben Trovado wrote: ↑Thu Jan 27, 2022 1:59 amNo idea. On balance, I support the vaccines for anyone over 50 definitely. Over 30 Probably. Over 15 Maybe, according to other factors. And under 15, probably not, according to other factors.Doctor X wrote: ↑Thu Jan 27, 2022 1:30 amWhat now?Ben Trovado wrote: ↑Wed Jan 26, 2022 11:39 pmI will say that the fact that the % of vaccinated people either hospitalized or dead match so closely to the % of people vaccinated overall. . . .
– J.D.
But I am just one rando looking out for himself and his kids.
Here's something that was just released by the state of Washington for example:
https://www.doh.wa.gov/Portals/1/Docume ... inated.pdf
Note that this is recent data, not from last summer. Hospitalization rates were 5 times higher in unvaccinated 12-34 year-olds and 7 times higher in people 35 or older. And from Dec. 1 to Dec. 28th death rates were 11 times higher for unvaccinated people over 65.COVID-19 hospitalization rates per 100,000 population from December 15 to
January 11, 2022
This data is about as recent as you are going to find. All within the last 2 months.
Using data from 19 early epicenters, we show that the relationship between the incidence of COVID-19 and temperature is a complex function of prevailing climatic conditions influencing human behavior that govern virus transmission dynamics. We note that under a dry (low-moisture) environment, notably at dew point temperatures below 0°C, the incidence of the disease was highest. Prevalence of the virus in the human population, when ambient air temperatures were higher than 24°C or lower than 17°C, was hypothesized to be a function of the interaction between humans and the built or ambient environment.